About the Product

Description


Biapair Injection contains Biapenem, a potent carbapenem antibiotic used to treat a broad spectrum of bacterial infections. Biapenem works by inhibiting bacterial cell wall synthesis, leading to the elimination of both gram-positive and gram-negative pathogens, including those resistant to other antibiotics. This makes it highly effective against severe and complicated infections.

Biapair Injection is primarily utilized in treating serious infections such as hospital-acquired pneumonia, complicated intra-abdominal infections, complicated urinary tract infections, and septicemia. Its broad-spectrum activity also covers multi-drug resistant organisms, making it a valuable option in critical care settings.

The formulation ensures rapid action, providing effective bacterial clearance and minimizing the risk of further complications. Biapair Injection is administered under medical supervision in hospital settings, ensuring precise dosage and monitoring to optimize patient outcomes.

May cause nausea, diarrhea, rash, injection site reactions, or headache. Rarely, allergic reactions or seizures may occur.

Used for treating severe bacterial infections, including hospital-acquired pneumonia, intra-abdominal infections, urinary tract infections, and septicemia.

Administer only under medical supervision. Inform the doctor about any history of allergies or existing medical conditions.

Store below 25°C in a cool, dry place. Protect from light and keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Biapenem 300mg Injection in the PCD pharma franchise market?

Biapenem 300mg Injection has strong demand in the hospital and critical care antibiotic segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotics.

Why should medical distributors include Biapenem Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for management of severe bacterial infections, especially in hospital settings such as: Complicated respiratory tract infections Urinary tract infections Intra-abdominal infections Skin and soft tissue infections Biapenem is a broad-spectrum carbapenem antibiotic used in resistant infections, strengthening a strong critical-care injectable portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Biapenem 300mg Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong hospital demand, ICU and emergency usage, high-value injectable antibiotic segment, institutional supply potential, and good margins when partnering for this critical-care product.

How can I become a distributor or franchise partner for Biapenem Injection?

Medical distributors, stockists, and wholesalers interested in Biapenem 300mg Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, pricing, and distribution support.